By Sheri Kasprzak
New York, Nov. 18 – The New Jersey Health Care Facilities Financing Authority priced $129,925,000 of series 2014A revenue refunding bonds for Barnabas Health, said a pricing sheet.
The bonds (A3/A-/A-) were sold through senior manager J.P. Morgan Securities LLC.
The bonds are due in 2044 with a 4.25% coupon priced at 98.669 to yield 4.33% and a 5% coupon priced at 108.054 to yield 3.98%.
Proceeds will be used to current refund the health system’s series 2012 taxable revenue bonds issued for Jersey City Medical Center.
| Issuer: | New Jersey Health Care Facilities Financing Authority/Barnabas Health
|
| Issue: | Series 2014A revenue refunding bonds
|
| Amount: | $129,925,000
|
| Type: | Negotiated
|
| Underwriter: | J.P. Morgan Securities LLC
|
| Ratings: | Moody’s: A3
|
| Standard & Poor’s: A-
|
| Fitch: A-
|
| Pricing date: | Nov. 18
|
| Settlement date: | Dec. 3
|
|
|
| Amount | Maturity | Type | Coupon | Price | Yield
|
| $29,925,000 | 2044 | Term | 4.25% | 98.669 | 4.33%
|
| $100 million | 2044 | Term | 5% | 108.054 | 3.98%
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
